FI
ABMD

FormulaFolio Investments’s Abiomed Inc ABMD Stock Holding History

FormulaFolio Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,588
Closed -$515K – 844
2020
Q4 		$515K Sell
1,588
-374
-19% -$103K 0.01% 435
2020
Q3 		$544K Buy
1,962
+257
+15% +$74K 0.02% 200
2020
Q2 		$412K Hold
1,705
– – 0.02% 207
2020
Q1 		$248K Hold
1,705
– – 0.01% 244
2019
Q4 		$291K Hold
1,705
– – 0.01% 311
2019
Q3 		$303K Sell
1,705
-326
-16% -$70.5K 0.01% 283
2019
Q2 		$529K Buy
2,031
+5
+0.2% +$1.33K 0.02% 199
2019
Q1 		$579K Sell
2,026
-2
-0.1% -$665 0.03% 181
2018
Q4 		$912K Hold
2,028
– – 0.04% 144
2018
Q3 		$912K Buy
+2,028
New +$799K 0.04% 143

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FormulaFolio Investments's ABMD Position: Q1 2021 in Review

FormulaFolio Investments sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 1,588 shares — an estimated $515K sold.

FormulaFolio Investments first reported a position in ABMD in Q3 2018 and held it in 10 quarters. The position peaked at $912K in Q4 2018. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • FormulaFolio Investments reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • FormulaFolio Investments sold 1,588 Abiomed Inc shares in Q1 2021, an estimated $515K.
  • FormulaFolio Investments first reported a position in Abiomed Inc in Q3 2018 and held it in 10 quarters.
  • FormulaFolio Investments's Abiomed Inc position peaked at $912K in Q4 2018.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on FormulaFolio Investments's 13F filing for Q1 2021, filed 28 May 2021.